 CONMED Co. NASDAQ:CNMD Investment analysts at Piper Sandler lowered their Q2 2021 earnings per share estimates for shares of CONMED in a research report issued to clients and investors on Wednesday, July 29th. Piper Sandler analyst M. Obrien now expects that the medical technology company will post earnings of 0.75 per share for the ... 